Theracurmin®

Drinkable preparation of Theracurmin exhibits high absorption efficiency–a single-dose, double-blind, 4-way crossover study.

Morimoto T, Sunagawa Y, Katanasaka Y, Hirano S, Namiki M, Watanabe Y, Suzuki H, Doi O, Suzuki K, Yamauchi M, Yokoji T, Miyoshi-Morimoto E, Otsuka Y, Hamada T, Imaizumi A, Nonaka Y, Fuwa T, Teramoto T, Kakeya H, Wada H, Hasegawa K.

Biol Pharm Bull. 2013; 36 (11): 1708-1714.

Short-term Effectiveness of Nexala® in the Treatment of Patients with Gonarthrosis and Coxarthrosis.

Pablo M, Nestor Z, Jorge L.

Jpn Pharmacol Ther 2021 49; (2): 229–238.

TC045

Innovative preparation of curcumin for improved oral bioavailability.

Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T.

Biol Pharm Bull. 2011; 34 (5): 660-665.

The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study.

Nakagawa Y, Mukai S, Yamada S, Murata S, Yabumoto H, Maeda T, Akamatsu S.

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2020 13: 1–8.
doi: 10.1177/1179544120948471.

TC044

The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain.

Erken N, Dost Gunay FS, Soysal P, Isik AT.

Clin Interv Aging. 2020 May 19;15:691-693. doi: 10.2147/CIA.S252229. eCollection 2020.

Short-term effects of Theracurmin dose and exercise type on pain, walking ability, and muscle function in patients with knee osteoarthritis.

Shin YA, Suk MH, Jang HS, Choi HJ.

J Exerc Rehabil. 2017 Dec; 13 (6): 684-692.

TC026